Professor Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been the principal investigator of several large, multicenter, randomized clinical trials investigating the use of image-guided interventions for the treatment of hepatocellular carcinoma and the potential synergies between loco-regional and systemic therapies.
Professor Lencioni has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma. He is also known for having developed
modified RECIST (mRECIST) criteria for the assessment of tumor response in hepatocellular carcinoma.

Riccardo Lencioni has published more than 200 articles in peer-reviewed international journals indexed in
PubMed and numerous chapters in textbooks of radiology, gastroenterology, oncology and surgery. In
addition, he has been the editor of nine books. According to the SCOPUS database, citations of his
publications currently number in excess of 26,000, for an h-index of 67.

HONOURS AND MEMBERSHIPS

• Founding Chairman of the European Conference of Interventional Oncology,
• co-Founder and Chairman of the World Conference of Interventional Oncology,
• Founding Governing Board Member and Executive Secretary of the International Liver Cancer Association.
• He has received numerous international awards for his research and has been an invited or honorary lecturer at more than 500 international meetings or conferences held in 65 different countries.